RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ICU Medical Stock

ICU Medical Revenue 2024

ICU Medical Revenue

2.35 B USD

Ticker

ICUI

ISIN

US44930G1076

WKN

894139

In 2024, ICU Medical's sales reached 2.35 B USD, a 3.8% difference from the 2.26 B USD sales recorded in the previous year.

The ICU Medical Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2028e2.628,46
2027e2.5229,40
2026e2.5129,44
2025e2.4430,34
2024e2.3531,55
20232.2632,75
20222.2830,61
20211.3237,34
20201.2736,31
20191.2737,27
20181.440,71
20171.2932,96
20160.3853,08
20150.3452,91
20140.3148,95
20130.3149,31
20120.3249,38
20110.347,12
20100.2845,58
20090.2346,42
20080.243,87
20070.1941,57
20060.240,03
20050.1644,06
20040.0847,22

ICU Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into ICU Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by ICU Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects ICU Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of ICU Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into ICU Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing ICU Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on ICU Medical’s growth potential.

ICU Medical Revenue, EBIT and net profit per share

DateICU Medical RevenueICU Medical EBITICU Medical Net Income
2028e2.6 B undefined0 undefined344.87 M undefined
2027e2.52 B undefined0 undefined302.26 M undefined
2026e2.51 B undefined275.6 M undefined211.16 M undefined
2025e2.44 B undefined318 M undefined169.91 M undefined
2024e2.35 B undefined264.53 M undefined129.32 M undefined
20232.26 B undefined64.08 M undefined-29.66 M undefined
20222.28 B undefined28.5 M undefined-74.3 M undefined
20211.32 B undefined141.4 M undefined103.1 M undefined
20201.27 B undefined125.6 M undefined86.9 M undefined
20191.27 B undefined193.7 M undefined101 M undefined
20181.4 B undefined176.8 M undefined28.8 M undefined
20171.29 B undefined64.7 M undefined68.6 M undefined
2016379.4 M undefined99 M undefined63.1 M undefined
2015341.7 M undefined81.9 M undefined45 M undefined
2014309.3 M undefined44.1 M undefined26.3 M undefined
2013313.7 M undefined53.3 M undefined40.4 M undefined
2012316.9 M undefined61.3 M undefined41.3 M undefined
2011302.2 M undefined48.5 M undefined44.7 M undefined
2010283 M undefined47.7 M undefined29.9 M undefined
2009229 M undefined35.4 M undefined25 M undefined
2008204.7 M undefined31.4 M undefined24.3 M undefined
2007188.1 M undefined24.6 M undefined23.1 M undefined
2006201.6 M undefined28.8 M undefined25.7 M undefined
2005157.5 M undefined27.6 M undefined20.3 M undefined
200475.6 M undefined5.9 M undefined5 M undefined

ICU Medical stock margins

The ICU Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ICU Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ICU Medical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the ICU Medical's sales revenue. A higher gross margin percentage indicates that the ICU Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the ICU Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the ICU Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the ICU Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the ICU Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the ICU Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

ICU Medical Margin History

ICU Medical Gross marginICU Medical Profit marginICU Medical EBIT marginICU Medical Profit margin
2028e32.75 %0 %13.26 %
2027e32.75 %0 %12.01 %
2026e32.75 %10.97 %8.4 %
2025e32.75 %13.04 %6.97 %
2024e32.75 %11.28 %5.51 %
202332.75 %2.84 %-1.31 %
202230.61 %1.25 %-3.26 %
202137.34 %10.74 %7.83 %
202036.31 %9.88 %6.84 %
201937.27 %15.3 %7.98 %
201840.71 %12.63 %2.06 %
201732.96 %5.01 %5.31 %
201653.08 %26.09 %16.63 %
201552.91 %23.97 %13.17 %
201448.95 %14.26 %8.5 %
201349.31 %16.99 %12.88 %
201249.38 %19.34 %13.03 %
201147.12 %16.05 %14.79 %
201045.58 %16.86 %10.57 %
200946.42 %15.46 %10.92 %
200843.87 %15.34 %11.87 %
200741.57 %13.08 %12.28 %
200640.03 %14.29 %12.75 %
200544.06 %17.52 %12.89 %
200447.22 %7.8 %6.61 %

ICU Medical Aktienanalyse

What does ICU Medical do?

ICU Medical Inc is a US medical technology company specializing in the development and production of innovative products for infusion and oncology therapy. It was founded in 1984 by Dr. George A. Lopez and has become a leading manufacturer of disposable products for infusion therapy. The company offers a wide range of disposable products for infusion and oncology therapy, including solutions, medication administration systems, catheters, syringes, tubes, and sensors. They also manufacture medical devices such as syringe pumps, medication administration pumps, and gravity infusion devices. ICU Medical Inc collaborates with other companies in the medical and pharmaceutical industries to provide comprehensive solutions for intravenous therapy. The company's product range includes syringes, tubes, catheters, combination products, infusion and syringe pumps, and the Clave technology for closed infusion pump systems. ICU Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding ICU Medical's Sales Figures

The sales figures of ICU Medical originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing ICU Medical’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize ICU Medical's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in ICU Medical’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about ICU Medical stock

How much revenue did ICU Medical generate this year?

ICU Medical has achieved a revenue of 2.35 B USD this year.

How much was the turnover of the company ICU Medical compared to the previous year?

The revenue of ICU Medical has increased by 3.8% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of ICU Medical?

The revenue of ICU Medical is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of ICU Medical measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of ICU Medical so important for investors?

The revenue of ICU Medical is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does ICU Medical pay?

Over the past 12 months, ICU Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ICU Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of ICU Medical?

The current dividend yield of ICU Medical is .

When does ICU Medical pay dividends?

ICU Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ICU Medical?

ICU Medical paid dividends every year for the past 0 years.

What is the dividend of ICU Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ICU Medical located?

ICU Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von ICU Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ICU Medical from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did ICU Medical pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of ICU Medical in the year 2023?

In the year 2023, ICU Medical distributed 0 USD as dividends.

In which currency does ICU Medical pay out the dividend?

The dividends of ICU Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ICU Medical

Our stock analysis for ICU Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ICU Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.